FluoroPharma Medical, based in Montclair, N.J., announced yesterday that new results from an ongoing phase II clinical trial for F-18 FCPHA cardiac PET for the diagnosis of acute coronary artery disease (CAD) were positive and providing validation for further research. {read more here}

A PET/CT study followed 40 sufferers of heart attacks and just as many matched controls imaged with conventional coronary angiography and sodium fluoride PET/CT to gauge vulnerable plaques and see potential risk of heart attack. {read more here}

Adverse reactions due to radiopharmaceuticals remained the same from 2007 to 2011, despite an increase in the number of PET exams during those five years, according to a study published online May 29 in the Journal of Nuclear Medicine. {read more here}

While the implementation of PACS in radiology brought a host of clinical benefits, it came with a downside: less interaction between radiologists and clinicians. An iPad application developed by a Johns Hopkins team offers the promise of recapturing the clinical and educational value of frequent face-to-face consultations.  {read more here}